These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35222752)

  • 21. Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation.
    Nielsen-Kudsk JE; Korsholm K; Damgaard D; Valentin JB; Diener HC; Camm AJ; Johnsen SP
    JACC Cardiovasc Interv; 2021 Jan; 14(1):69-78. PubMed ID: 33413867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of direct oral anticoagulants (DOACs) versus vitamin K antagonist (VKA) among patients with atrial fibrillation and hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Rujirachun P; Charoenngam N; Wattanachayakul P; Winijkul A; Owattanapanich W; Ungprasert P
    Acta Cardiol; 2020 Dec; 75(8):724-731. PubMed ID: 31558097
    [No Abstract]   [Full Text] [Related]  

  • 23. Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation.
    Brown JD; Shewale AR; Talbert JC
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1319-1329. PubMed ID: 27783556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adequate Adherence to Direct Oral Anticoagulant is Associated with Reduced Ischemic Stroke Severity in Patients with Atrial Fibrillation.
    Yamashiro K; Kurita N; Tanaka R; Ueno Y; Miyamoto N; Hira K; Nakajima S; Urabe T; Hattori N
    J Stroke Cerebrovasc Dis; 2019 Jun; 28(6):1773-1780. PubMed ID: 30318259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating Adherence Based on Prescription or Dispensation Information: Impact on Thresholds and Outcomes. A Real-World Study With Atrial Fibrillation Patients Treated With Oral Anticoagulants in Spain.
    Hurtado-Navarro I; García-Sempere A; Rodríguez-Bernal C; Santa-Ana-Tellez Y; Peiró S; Sanfélix-Gimeno G
    Front Pharmacol; 2018; 9():1353. PubMed ID: 30559661
    [No Abstract]   [Full Text] [Related]  

  • 26. Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight.
    Lee SR; Choi EK; Park CS; Han KD; Jung JH; Oh S; Lip GYH
    J Am Coll Cardiol; 2019 Mar; 73(8):919-931. PubMed ID: 30819360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation.
    Giustozzi M; Mazzetti M; Paciaroni M; Agnelli G; Becattini C; Vedovati MC
    Clin Drug Investig; 2021 Jan; 41(1):43-51. PubMed ID: 33284370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adherence with direct oral anticoagulants in nonvalvular atrial fibrillation new users and associated factors: a French nationwide cohort study.
    Maura G; Pariente A; Alla F; Billionnet C
    Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1367-1377. PubMed ID: 28752560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LDL Cholesterol and Ischemic Stroke in Patients with Nonvalvular Atrial Fibrillation.
    Omelchenko A; Hornik-Lurie T; Gabay H; Minha S; Assali A; Pereg D
    Am J Med; 2021 Apr; 134(4):507-513. PubMed ID: 33002488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of patient satisfaction with direct oral anticoagulants and the clinical outcomes: Findings from the SAKURA AF registry.
    Hori K; Okumura Y; Koichi N; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Kojima T; Arima K; Kotani T; Nomoto K; Ohkubo K; Fukushima S; Onikura M; Suzuki Y; Fujita M; Ando H; Ishikawa N; Hirayama A;
    J Cardiol; 2020 Jul; 76(1):80-86. PubMed ID: 32089481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can Direct Oral Anticoagulants Be Used for Stroke Prevention Among Patients with Valvular Atrial Fibrillation?
    Anderson SL; Marrs JC
    Curr Cardiol Rep; 2019 Aug; 21(10):118. PubMed ID: 31473836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct oral anticoagulants and the risk of osteoporotic fractures in patients with non-valvular atrial fibrillation.
    Kuo LT; Lin SJ; Wu VC; Chang JJ; Chu PH; Lin YS
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X211011374. PubMed ID: 33995605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease.
    Lopes RD; Steffel J; Di Fusco M; Keshishian A; Luo X; Li X; Masseria C; Hamilton M; Friend K; Gupta K; Mardekian J; Pan X; Baser O; Jones WS
    Am J Med; 2018 Sep; 131(9):1075-1085.e4. PubMed ID: 29807001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation.
    Raposeiras-Roubín S; Alonso Rodríguez D; Camacho Freire SJ; Abu-Assi E; Cobas-Paz R; Rodríguez Pascual C; García Comesaña J; González-Carrero López A; Cubelos Fernández N; López-Masjuán Ríos Á; Cespón-Fernández M; Muñoz-Pousa I; Caneiro-Queija B; Rodríguez Albarrán A; Castañera SÁ; Guillén JV; Carpintero Vara A; Barreiro Pardal C; Domínguez-Erquicia P; Domínguez-Rodríguez LM; Díaz Fernández JF; Fernández Vázquez F; Iñíguez-Romo A
    J Am Med Dir Assoc; 2020 Mar; 21(3):367-373.e1. PubMed ID: 31753740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [THE COMPLIANCE AND ADHERENCE TO DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH A TRIAL FIBRILLATION AFTER HOSPITALIZATION].
    Elis A; Ayada G; Othman I; Atamna A
    Harefuah; 2021 Aug; 160(8):501-504. PubMed ID: 34396724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Depression and Adherence to Oral Anticoagulation in Patients With Atrial Fibrillation.
    Lapa ME; Swabe GM; Magnani JW
    J Am Heart Assoc; 2023 Nov; 12(22):e031281. PubMed ID: 37982265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Effectiveness and Safety of Low-Dose Oral Anticoagulants in Patients With Atrial Fibrillation.
    Perreault S; Dragomir A; Côté R; Lenglet A; de Denus S; Dorais M; White-Guay B; Brophy J; Schnitzer ME; Dubé MP; Tardif JC
    Front Pharmacol; 2021; 12():812018. PubMed ID: 35095525
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of medication adherence on risk of ischemic stroke, major bleeding and deep vein thrombosis in atrial fibrillation patients using novel oral anticoagulants.
    Deshpande CG; Kogut S; Laforge R; Willey C
    Curr Med Res Opin; 2018 Jul; 34(7):1285-1292. PubMed ID: 29334815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimated Thresholds of Minimum Necessary Adherence for Effective Treatment with Direct Oral Anticoagulants - A Retrospective Cohort Study in Health Insurance Claims Data.
    Wirbka L; Haefeli WE; Meid AD;
    Patient Prefer Adherence; 2021; 15():2209-2220. PubMed ID: 34594102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for stroke and choice of oral anticoagulant in atrial fibrillation.
    Kjerpeseth LJ; Ellekjær H; Selmer R; Ariansen I; Furu K; Skovlund E
    Eur J Clin Pharmacol; 2018 Dec; 74(12):1653-1662. PubMed ID: 30116828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.